Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02368951
Brief Title: Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)

First Submitted : February 16, 2015
First Submitted that Met QC Criteria : February 16, 2015
First Posted : February 23, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 10, 2017
Last Update Posted : July 12, 2017